Delivery Order SPE2DB22D3016-SPE2DB24FAZB7
Award Date
6/21/24
Potential Completion Date
6/24/24
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $2,580.75 firm fixed price contract is for the supply of Gadavist 10 mmol/10 ml vials, with a performance period ending March 11, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Gadavist 10 mmol/10 ml vials. The $4,729.46 order has a completion date of January 30, 2024 and does not fall under any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Gadavist, a pharmaceutical product, with a ceiling value of $1,062.40 and an ultimate completion date of January 21, 2025. The contract is a firm-fixed-price delivery order, which is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Gadavist 1 mmol/ml bulk vial (30 ml). The firm-fixed-price delivery order, valued at $4,546.40, has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Gadavist 10 mL vials, a specialty pharmaceutical product. The contract has a firm fixed price of $2,239.12 and a period of performance through October 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as well as larger Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Gadavist 1 mmol/ml bulk vials (30 ml) and has a ceiling value of $1,711.35. The delivery order is part of a larger indefinite delivery contract (IDC) that AmerisourceBergen Drug Corp holds with DLA, which has a potential value of $999,999,999.00 through December 31, 2025....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Gadavist, a medical contrast agent, in 30 ml vials. The award, valued at $1,140.90, is a firm fixed-price delivery order contract with a completion date of May 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Gadavist, a 1 mmol/ml bulk medication vial. The delivery order has a ceiling value of $1,711.35 and a period of performance through October 17, 2024. This award is not designated as a set-aside contract. The contract is a Firm Fixed Price delivery order under a larger Indefinite Delivery Contract (IDC) held...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order, valued at $1,553.60, is for the supply of Gadavist, a 10 milliliter vial of a 10 millimolar per milliliter contrast agent used in medical imaging. The delivery order does not have a set-aside designation and is part of a larger $999,999,999.00 indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,062.40, is for the delivery of GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of January 24, 2025. This Delivery Order is issued under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...